The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Donor-Transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk
Open accessAbstract
The continuing organ shortage requires evaluation of all potential donors, including those with malignant disease. In the United States, no organized approach to assessment of risk of donor tumor transmission exists, and organs from such donors are often discarded. The ad hoc Disease Transmission Advisory Committee (DTAC) of the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) formed an ad hoc Malignancy Subcommittee to advise on this subject. The Subcommittee reviewed the largely anecdotal literature and held discussions to generate a framework to approach risk evaluation in this circumstance. Six levels of risk developed by consensus. Suggested approach to donor utilization is given for each category, recognizing the primacy of individual clinical judgment and often emergent clinical circumstances. Categories are populated with specific tumors based on available data, including active or historical cancer. Benign tumors are considered in relation to risk of malignant transformation. Specific attention is paid to potential use of kidneys harboring small solitary renal cell carcinomas, and to patients with central nervous system tumors. This resource document is tailored to clinical practice in the United States and should aid clinical decision making in the difficult circumstance of an organ donor with potential or proven neoplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Armanios, M. Y., Grossman, S. A., Yang, S. C., White, B., Perry, A., Burger, P. C., & Orens, J. B. (2004) · Neuro-Oncology · doi:10.1215/s1152851703000474 · Cited by 80
Cited by
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors
Lentine, K. L., Kasiske, B. L., Levey, A. S., Adams, P. L., Alberú, J., Bakr, M. A., Gallon, L., Garvey, C. A., Guleria, S., Li, P. K.-T., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001769 · Cited by 582
Hematogenous dissemination of glioblastoma multiforme
Müller, C., Holtschmidt, J., Auer, M., Heitzer, E., Lamszus, K., Schulte, A., Matschke, J., Langer-Freitag, S., Gasch, C., Stoupiec, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009095 · Cited by 328
Cancer in the Transplant Recipient
Chapman, J. R., Webster, A. C., & Wong, G. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015677 · Cited by 275
EASL Clinical Practice Guidelines on liver transplantation
Samuel, D., De Martin, E., Berg, T., Berenguer, M., Burra, P., Fondevila, C., Heimbach, J. K., Pageaux, G.-P., Sanchez-Fueyo, A., & Toso, C. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.07.032 · Cited by 263
Cancer in kidney transplant recipients
Au, E., Wong, G., & Chapman, J. R. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0022-6 · Cited by 262
Metadata
- Authors
- Nalesnik, M. A., Woodle, E. S., DiMaio, J. M., Vasudev, B., Teperman, L. W., Covington, S., Taranto, S., Gockerman, J. P., Shapiro, R., Sharma, V., Swinnen, L. J., Yoshida, A., & Ison, M. G.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 11
- Issue
- 6
- Pages
- 1140-1147
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W1482740385
- Cited by
- 211
- References
- 1
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Donor-Transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk. https://app.cochat.ai/papers/10.1111/j.1600-6143.2011.03565.x
- The paper
- Nalesnik, M. A., Woodle, E. S., DiMaio, J. M., Vasudev, B., Teperman, L. W., Covington, S., Taranto, S., Gockerman, J. P., Shapiro, R., Sharma, V., Swinnen, L. J., Yoshida, A., & Ison, M. G. (2011). Donor-Transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk. American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2011.03565.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.